170 related articles for article (PubMed ID: 21791936)
1. Indomethacin impairs coronary perfusion in infants with hemodynamically significant ductus arteriosus.
Sehgal A; Ramsden CA; McNamara PJ
Neonatology; 2012; 101(1):20-7. PubMed ID: 21791936
[TBL] [Abstract][Full Text] [Related]
2. A Hemodynamically Significant Patent Ductus Arteriosus Does Not Affect Cerebral or Renal Tissue Oxygenation in Preterm Infants.
van der Laan ME; Roofthooft MT; Fries MW; Berger RM; Schat TE; van Zoonen AG; Tanis JC; Bos AF; Kooi EM
Neonatology; 2016; 110(2):141-7. PubMed ID: 27088709
[TBL] [Abstract][Full Text] [Related]
3. Impact of patent ductus arteriosus and subsequent therapy with indomethacin on cerebral oxygenation in preterm infants.
Lemmers PM; Toet MC; van Bel F
Pediatrics; 2008 Jan; 121(1):142-7. PubMed ID: 18166568
[TBL] [Abstract][Full Text] [Related]
4. Cyclooxygenase inhibitors in preterm infants with patent ductus arteriosus: effects on cardiac and vascular indices.
Sehgal A; Doctor T; Menahem S
Pediatr Cardiol; 2014 Dec; 35(8):1429-36. PubMed ID: 24894898
[TBL] [Abstract][Full Text] [Related]
5. Neonatal necrotizing enterocolitis with intestinal perforation in extremely premature infants receiving early indomethacin treatment for patent ductus arteriosus.
Fujii AM; Brown E; Mirochnick M; O'Brien S; Kaufman G
J Perinatol; 2002; 22(7):535-40. PubMed ID: 12368968
[TBL] [Abstract][Full Text] [Related]
6. Cerebral blood flow velocity changes in preterm infants after a single dose of indomethacin: duration of its effect.
Van Bel F; Van de Bor M; Stijnen T; Baan J; Ruys JH
Pediatrics; 1989 Nov; 84(5):802-7. PubMed ID: 2677960
[TBL] [Abstract][Full Text] [Related]
7. Consequences of delayed surgical closure of patent ductus arteriosus in very premature infants.
Jaillard S; Larrue B; Rakza T; Magnenant E; Warembourg H; Storme L
Ann Thorac Surg; 2006 Jan; 81(1):231-4. PubMed ID: 16368371
[TBL] [Abstract][Full Text] [Related]
8. High efficacy and minor renal effects of indomethacin treatment during individualized fluid intake in premature infants with patent ductus arteriosus.
Leonhardt A; Strehl R; Barth H; Seyberth HW
Acta Paediatr; 2004 Feb; 93(2):233-40. PubMed ID: 15046280
[TBL] [Abstract][Full Text] [Related]
9. Clinical aspects of very-low-birthweight infants showing reopening of ductus arteriosus.
Uchiyama A; Nagasawa H; Yamamoto Y; Tatebayashi K; Suzuki H; Yamada K; Arai M; Kohno Y
Pediatr Int; 2011 Jun; 53(3):322-7. PubMed ID: 20854286
[TBL] [Abstract][Full Text] [Related]
10. Effect of early targeted indomethacin on the ductus arteriosus and blood flow to the upper body and brain in the preterm infant.
Osborn DA; Evans N; Kluckow M
Arch Dis Child Fetal Neonatal Ed; 2003 Nov; 88(6):F477-82. PubMed ID: 14602694
[TBL] [Abstract][Full Text] [Related]
11. Regional cerebral blood flow velocity changes after indomethacin infusion in preterm infants.
Austin NC; Pairaudeau PW; Hames TK; Hall MA
Arch Dis Child; 1992 Jul; 67(7 Spec No):851-4. PubMed ID: 1519988
[TBL] [Abstract][Full Text] [Related]
12. Continuous infusion of ibuprofen for treatment of patent ductus arteriosus in very low birth weight infants.
Lago P; Salvadori S; Opocher F; Ricato S; Chiandetti L; Frigo AC
Neonatology; 2014; 105(1):46-54. PubMed ID: 24281435
[TBL] [Abstract][Full Text] [Related]
13. [Dopplersonographic findings in neonates with significant persistent ductus arteriosus].
Robel-Tillig E; Knüpfer M; Pulzer F; Vogtmann C
Z Geburtshilfe Neonatol; 2002 Apr; 206(2):51-6. PubMed ID: 12015635
[TBL] [Abstract][Full Text] [Related]
14. Comparative evaluation for the use of oral ibuprofen and intravenous indomethacin in Korean infants with patent ductus.
Heo MJ; Lee OS; Lim SC
Arch Pharm Res; 2012 Sep; 35(9):1673-83. PubMed ID: 23054725
[TBL] [Abstract][Full Text] [Related]
15. Hemodynamic Effects on Systemic Blood Flow and Ductal Shunting Flow after Loading Dose of Intravenous Caffeine in Preterm Infants according to the Patency of Ductus Arteriosus.
Hwang J; Kim YS; Shin JH; Choi BM
J Korean Med Sci; 2018 Jan; 33(4):e25. PubMed ID: 29318792
[TBL] [Abstract][Full Text] [Related]
16. Early signs that predict later haemodynamically significant patent ductus arteriosus.
Engür D; Deveci M; Türkmen MK
Cardiol Young; 2016 Mar; 26(3):439-45. PubMed ID: 25826049
[TBL] [Abstract][Full Text] [Related]
17. Coronary artery perfusion and myocardial performance after patent ductus arteriosus ligation.
Sehgal A; McNamara PJ
J Thorac Cardiovasc Surg; 2012 Jun; 143(6):1271-8. PubMed ID: 22153859
[TBL] [Abstract][Full Text] [Related]
18. Oral ibuprofen and indomethacin for treatment of patent ductus arteriosus in premature infants: a randomized trial at Ramathibodi Hospital.
Supapannachart S; Limrungsikul A; Khowsathit P
J Med Assoc Thai; 2002 Nov; 85 Suppl 4():S1252-8. PubMed ID: 12549803
[TBL] [Abstract][Full Text] [Related]
19. Randomized trial of prolonged low-dose versus conventional-dose indomethacin for treating patent ductus arteriosus in very low birth weight infants.
Lee J; Rajadurai VS; Tan KW; Wong KY; Wong EH; Leong JY
Pediatrics; 2003 Aug; 112(2):345-50. PubMed ID: 12897285
[TBL] [Abstract][Full Text] [Related]
20. The serial changes of perfusion index in preterm infants with patent ductus arteriosus: is perfusion index clinically significant?
Terek D; Altun Koroglu O; Ulger Z; Yalaz M; Kultursay N
Minerva Pediatr; 2016 Aug; 68(4):250-5. PubMed ID: 27277201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
